Meet The CEOs

Emyria Limited (ASX: EMD) CEO Dr Michael Winlo discusses why the company is well positioned to rapidly and repeatedly develop new treatments as well as its key partnerships, recent achievements and strategic plans for the upcoming year.

Emyria Limited (ASX: EMD) is a data-backed, drug development company. Emyria’s Treatments target unmet needs and are focused on obtaining approval from major global regulators.

Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
Accurate time of recording, 17 February 2021, 12pm AEDT.

What is Meet The CEOs?

Get a seat at the table and hear directly from CEOs and business leaders. Each week we are joined by three CEOs of exciting ASX listed businesses, who provide valuable insight to their industries, growing market opportunities and companies future prospects.